Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
17.30
-1.30 (-6.99%)
At close: Nov 12, 2026, 4:00 PM EST
16.98
-0.32 (-1.85%)
After-hours: Nov 12, 2026, 7:55 PM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $37.99 million as of November 12, 2026. It is the 31,959th most valuable company in the world and the 4,747th biggest in the United States. Its market cap has increased by 15.63% in one year.
Market Cap
37.99M
Enterprise Value
39.18M
1-Year Change
15.63%
Global Rank
Country Rank
#4,747 United States
Category
ChartMarket Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $37.99M, a decrease of -70.68%. That is a compound annual growth rate of -21.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 37.99M | -5.31% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 43.15M |
| Instil Bio | 43.07M |
| Connect Biopharma Holdings | 42.96M |
| Telomir Pharmaceuticals | 42.12M |
| OS Therapies | 41.12M |
| Hyperion DeFi | 40.25M |
| Biomea Fusion | 39.65M |
| Impact BioMedical | 39.47M |